Welder A A, Grant R, Bradlaw J, Acosta D
College of Pharmacy, University of Oklahoma Health Sciences Center, Division of Medicinal Chemistry and Pharmacodynamics, Oklahoma City 73190.
In Vitro Cell Dev Biol. 1991 Dec;27A(12):921-6. doi: 10.1007/BF02631118.
Tricyclic antidepressants (TCAs) are currently used in the treatment of mental depression and nocturnal enuresis. Clinically, these drugs are useful; however, cardiotoxicity can occur even with therapeutic dosages. For example, TCAs are known to alter myocardial function, induce arrhythmias, and produce heart block in individuals with a normal cardiovascular history. The present study was undertaken to establish a culture system of spontaneously contracting adult primary myocardial cells for toxicologic testing and to examine their contractility, morphology, and lactate dehydrogenase release (LDH) after treatment with one of the most cardiotoxic TCAs, amitriptyline. Primary myocardial cell cultures were obtained from approximately 60- to 90-day-old Sprague-Dawley rats. After the cells had been grown in culture for 11 days, they were treated with amitriptyline (1 x 10(-3), 1 x 10(-4), and 1 x 10(-5) M) for 2 to 24 h. The highest concentration of amitriptyline (1 x 10(-3) M) completely destroyed the cardiac muscle cells. In addition to moderate and severe vacuole, granule, and pseudopodia formation, all contractile activity was inhibited as early as 2 h after exposure to the intermediate concentration of 1 x 10(-4) M amitriptyline. Significant LDH release did not occur until 8 h after treatment with this intermediate concentration. Even though there was no significant LDH release at all 3 time points tested, there was a 50% decrease in beating activity (154 +/- 9 to 77 +/- 5 beats/min) and initiation of vacuole formation by 2 h with the lowest concentration of amitriptyline (1 x 10(-5) M). This study presents a new apparatus for the isolation of adult cardiac myocytes for the establishment of primary cell cultures for toxicologic testing. Furthermore, these data demonstrate that amitriptyline induces a concentration- and time-dependent cardiotoxic profile in a model of spontaneously contracting adult cardiac muscle cells in culture.
三环类抗抑郁药(TCAs)目前用于治疗精神抑郁症和夜间遗尿症。临床上,这些药物是有效的;然而,即使是治疗剂量也可能发生心脏毒性。例如,已知三环类抗抑郁药会改变心肌功能、诱发心律失常,并在心血管病史正常的个体中导致心脏传导阻滞。本研究旨在建立一种用于毒理学测试的成年原发性心肌细胞自发收缩培养系统,并在用最具心脏毒性的三环类抗抑郁药之一阿米替林处理后检查其收缩性、形态和乳酸脱氢酶释放(LDH)。从大约60至90日龄的Sprague-Dawley大鼠中获得原代心肌细胞培养物。细胞在培养中生长11天后,用阿米替林(1×10⁻³、1×10⁻⁴和1×10⁻⁵ M)处理2至24小时。最高浓度的阿米替林(1×10⁻³ M)完全破坏了心肌细胞。除了中度和重度空泡、颗粒和伪足形成外,早在暴露于1×10⁻⁴ M阿米替林的中间浓度2小时后,所有收缩活动就受到抑制。在用这种中间浓度处理8小时后才出现显著的LDH释放。尽管在所有3个测试时间点均未出现显著的LDH释放,但在用最低浓度的阿米替林(1×10⁻⁵ M)处理2小时时,搏动活动下降了50%(从154±9次/分钟降至77±5次/分钟),并开始形成空泡。本研究提出了一种用于分离成年心肌细胞以建立用于毒理学测试的原代细胞培养物的新装置。此外,这些数据表明,在培养的成年自发收缩心肌细胞模型中,阿米替林诱导了浓度和时间依赖性的心脏毒性特征。